 Hi, Tim. The U.S. Supreme Court tossed out Purdue Pharma's $6 billion opioid settlement, opening a new chapter of uncertainty for that company, ruling that the accord would improperly shield the Sackler family owners. The 5-4 ruling scuttles a plan that would have ended a mountain of civil litigation against the OxyContin maker, funneled billions of dollars toward efforts to abate the opioid crisis.